We Think Heilongjiang ZBD Pharmaceutical (SHSE:603567) Can Stay On Top Of Its Debt

Simply Wall StOct 3 23:52 ET

China Rejects ZBD Pharmaceutical's Application For Skin Infection Drug

MT NewswiresAug 27 01:56 ET

Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

SZSIAug 26 12:00 ET · Announcements

Summary of the 2024 semi-annual report of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

SZSIAug 26 12:00 ET · Announcements

Improved Earnings Required Before Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Shares Find Their Feet

Simply Wall StAug 20 23:34 ET

Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Annual Report 2023 - Revised Edition Summary.

SZSIAug 7 12:00 ET · Announcements